npub1psdfxfpxz2cwmmnsk60y3nqpn2tqh9n24h4hstvfkwvr6eaek9js499sr7 (npub1psd…9sr7)
Clearly there are valid circumstances for independent review but "we want more profit" shouldn't be one, imho.
Developing drugs is crazily expensive so it's not unreasonable to initially charge a lot.